Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Next generation of trials with targeted agents

Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)
Next generation of trials with targeted agents ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
6 Jul 2015

The importance of target expression in personalised medicine

Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
The importance of target expression in personalised medicine ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Jul 2015

Taking biopsies in clinical trials: The WINTHER laboratory experience

Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Taking biopsies in clinical trials: The WINTHER laboratory experience ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Jul 2015

Meta-analysis confirms benefits and safety of precision medicine

Prof Razelle Kurzrock - University of California, San Diego, USA
Meta-analysis confirms benefits and safety of precision medicine ( Prof Razelle Kurzrock - University of California, San Diego, USA )
3 Jul 2015

SPECTAlung: improving clinical trial access for patients with thoracic tumours

Dr Jessica Menis and Dr Benjamin Besse
SPECTAlung: improving clinical trial access for patients with thoracic tumours ( Dr Jessica Menis and Dr Benjamin Besse )
3 Jul 2015

Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL

Dr Paula Cramer - University of Cologne, Köln, Germany
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL ( Dr Paula Cramer - University of Cologne, Köln, Germany )
30 Jun 2015

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015

TAT 2016: Targeted anticancer therapies

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA
TAT 2016: Targeted anticancer therapies ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )
19 Jun 2015

EHA 2015 highlights

Peter Goodwin - ecancer reporter
EHA 2015 highlights ( Peter Goodwin - ecancer reporter )
17 Jun 2015

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )
16 Jun 2015

Biomarkers for childhood relapsed acute lymphoblastic leukaemia

Prof Anthony Moorman - Newcastle University, Newcastle, UK
Biomarkers for childhood relapsed acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )
16 Jun 2015

Exciting update on the Repurposing Drugs in Oncology (ReDO) project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium
Exciting update on the Repurposing Drugs in Oncology (ReDO) project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )
15 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation